Joshua A. Lee
Edmonton, AB, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Direct Reprogramming of Human DMD Fibroblasts into Myotubes for In Vitro Evaluation of Antisense-Mediated Exon Skipping and Exons 45-55 Skipping Accompanied by Rescue of Dystrophin Expression.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: July 28, 2025
Direct Reprogramming of Human DMD Fibroblasts into Myotubes for In Vitro Evaluation of Antisense-Mediated Exon Skipping and Exons 45-55 Skipping Accompanied by Rescue of Dystrophin Expression.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: September 02, 2018
Identification of Novel Antisense-Mediated Exon Skipping Targets in DYSF for Therapeutic Treatment of Dysferlinopathy.
Journal: Molecular therapy. Nucleic acids
Published: July 09, 2018
Cell Membrane Repair Assay Using a Two-photon Laser Microscope.
Journal: Journal of visualized experiments : JoVE
Published: January 25, 2018
Quantitative Antisense Screening and Optimization for Exon 51 Skipping in Duchenne Muscular Dystrophy.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: April 19, 2017
Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy.
Journal: Journal of visualized experiments : JoVE
Published: June 11, 2016
New developments in exon skipping and splice modulation therapies for neuromuscular diseases.
Journal: Expert opinion on biological therapy
Published: March 14, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026